Lifecore Biomedical (LFCR) Competitors $7.24 +0.17 (+2.40%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends LFCR vs. RCKT, AVDL, BCYC, COLL, SEPN, BCAX, ZYME, GYRE, PSTX, and COGTShould you be buying Lifecore Biomedical stock or one of its competitors? The main competitors of Lifecore Biomedical include Rocket Pharmaceuticals (RCKT), Avadel Pharmaceuticals (AVDL), Bicycle Therapeutics (BCYC), Collegium Pharmaceutical (COLL), Septerna (SEPN), Bicara Therapeutics (BCAX), Zymeworks (ZYME), Gyre Therapeutics (GYRE), Poseida Therapeutics (PSTX), and Cogent Biosciences (COGT). These companies are all part of the "pharmaceutical products" industry. Lifecore Biomedical vs. Rocket Pharmaceuticals Avadel Pharmaceuticals Bicycle Therapeutics Collegium Pharmaceutical Septerna Bicara Therapeutics Zymeworks Gyre Therapeutics Poseida Therapeutics Cogent Biosciences Lifecore Biomedical (NASDAQ:LFCR) and Rocket Pharmaceuticals (NASDAQ:RCKT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, community ranking, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation. Do analysts rate LFCR or RCKT? Lifecore Biomedical currently has a consensus price target of $10.00, suggesting a potential upside of 38.12%. Rocket Pharmaceuticals has a consensus price target of $48.80, suggesting a potential upside of 322.15%. Given Rocket Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Rocket Pharmaceuticals is more favorable than Lifecore Biomedical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Lifecore Biomedical 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Rocket Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.92 Which has more volatility & risk, LFCR or RCKT? Lifecore Biomedical has a beta of 0.99, indicating that its stock price is 1% less volatile than the S&P 500. Comparatively, Rocket Pharmaceuticals has a beta of 1.01, indicating that its stock price is 1% more volatile than the S&P 500. Which has better earnings & valuation, LFCR or RCKT? Lifecore Biomedical has higher revenue and earnings than Rocket Pharmaceuticals. Rocket Pharmaceuticals is trading at a lower price-to-earnings ratio than Lifecore Biomedical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifecore Biomedical$128.44M2.08$12.01M$0.0890.50Rocket PharmaceuticalsN/AN/A-$245.60M-$2.75-4.20 Does the MarketBeat Community favor LFCR or RCKT? Rocket Pharmaceuticals received 387 more outperform votes than Lifecore Biomedical when rated by MarketBeat users. Likewise, 73.17% of users gave Rocket Pharmaceuticals an outperform vote while only 27.27% of users gave Lifecore Biomedical an outperform vote. CompanyUnderperformOutperformLifecore BiomedicalOutperform Votes327.27% Underperform Votes872.73% Rocket PharmaceuticalsOutperform Votes39073.17% Underperform Votes14326.83% Do institutionals and insiders hold more shares of LFCR or RCKT? 83.4% of Lifecore Biomedical shares are held by institutional investors. Comparatively, 98.4% of Rocket Pharmaceuticals shares are held by institutional investors. 28.2% of Lifecore Biomedical shares are held by insiders. Comparatively, 28.5% of Rocket Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media prefer LFCR or RCKT? In the previous week, Rocket Pharmaceuticals had 13 more articles in the media than Lifecore Biomedical. MarketBeat recorded 15 mentions for Rocket Pharmaceuticals and 2 mentions for Lifecore Biomedical. Rocket Pharmaceuticals' average media sentiment score of 0.80 beat Lifecore Biomedical's score of 0.35 indicating that Rocket Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lifecore Biomedical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Rocket Pharmaceuticals 6 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Is LFCR or RCKT more profitable? Lifecore Biomedical has a net margin of 5.09% compared to Rocket Pharmaceuticals' net margin of 0.00%. Rocket Pharmaceuticals' return on equity of -62.62% beat Lifecore Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Lifecore Biomedical5.09% -382.65% -10.21% Rocket Pharmaceuticals N/A -62.62%-54.17% SummaryRocket Pharmaceuticals beats Lifecore Biomedical on 11 of the 17 factors compared between the two stocks. Ad DTICackling Kamala hates this companyDo you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFCR vs. The Competition Export to ExcelMetricLifecore BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$266.63M$6.57B$5.12B$9.07BDividend YieldN/A2.98%4.91%4.22%P/E Ratio90.5010.5991.3417.19Price / Sales2.08195.381,117.70116.80Price / CashN/A57.1642.6437.86Price / Book19.575.104.794.78Net Income$12.01M$151.51M$120.07M$225.60M7 Day Performance-4.86%-2.15%-1.90%-1.23%1 Month Performance3.72%-3.14%11.45%3.37%1 Year Performance19.67%11.50%30.63%16.58% Lifecore Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFCRLifecore Biomedical2.9045 of 5 stars$7.24+2.4%$10.00+38.1%+18.7%$266.63M$128.44M90.50690High Trading VolumeRCKTRocket Pharmaceuticals4.8477 of 5 stars$11.76-2.2%$51.00+333.7%-58.6%$1.07BN/A-4.37240Analyst ForecastAVDLAvadel Pharmaceuticals2.6635 of 5 stars$11.10+6.8%$24.43+120.1%-24.0%$1.07B$138.16M-13.15154Positive NewsBCYCBicycle Therapeutics3.6062 of 5 stars$15.22+10.2%$36.00+136.5%-18.8%$1.05B$26.98M-4.56240Analyst ForecastInsider TradeAnalyst RevisionNews CoverageHigh Trading VolumeCOLLCollegium Pharmaceutical3.8414 of 5 stars$30.72+2.1%$42.60+38.7%-0.4%$990.72M$599.25M12.97210News CoveragePositive NewsSEPNSepterna2.2189 of 5 stars$21.69-3.1%$43.67+101.3%N/A$963.04MN/A0.00N/ABCAXBicara TherapeuticsN/A$17.46-0.2%$43.00+146.3%N/A$950.10MN/A0.0032News CoverageGap DownZYMEZymeworks2.8055 of 5 stars$13.77+9.5%$18.83+36.8%+52.5%$948.48M$76.01M-9.25290Analyst ForecastNews CoverageGap DownGYREGyre Therapeutics0.6053 of 5 stars$9.97+3.4%N/A-61.2%$932.40M$105.03M0.0040News CoveragePositive NewsPSTXPoseida Therapeutics3.7522 of 5 stars$9.51flat$9.50-0.1%+193.5%$929.79M$64.70M-15.10260COGTCogent Biosciences1.9533 of 5 stars$8.31+2.0%$14.83+78.5%+51.9%$917.92MN/A-3.2980 Related Companies and Tools Related Companies Rocket Pharmaceuticals Competitors Avadel Pharmaceuticals Competitors Bicycle Therapeutics Competitors Collegium Pharmaceutical Competitors Septerna Competitors Bicara Therapeutics Competitors Zymeworks Competitors Gyre Therapeutics Competitors Poseida Therapeutics Competitors Cogent Biosciences Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:LFCR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
